The impact of dose-escalated RT on ADT in patients with intermediate risk prostate cancer

被引：0
|
作者：
Onal, Cem [1 ,2 ]
Guler, Ozan Cem [1 ]
Erbay, Gurcan [3 ]
Elmali, Aysenur [2 ]
机构：
[1] Baskent Univ, Dept Radiat Oncol, Fac Med, Adana, Turkiye
[2] Baskent Univ, Dept Radiat Oncol, Fac Med, Ankara, Turkiye
[3] Baskent Univ, Dept Radiol, Fac Med, Adana, Turkiye
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
ADT; Prostate cancer; Radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126
引用
收藏
页码：S2293 / S2294
页数：2
相关论文
共 50 条
  • [1] Short-Term ADT and Dose-Escalated IMRT in Patients with Intermediate-Risk Prostate Cancer: Benefit or Caution?
    Hung, Arthur
    Kahn, Jenna
    Turina, Claire
    Beer, Tomasz
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S66 - S67
  • [2] Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer Benefit or Caution?
    Post, Carl M.
    Kahn, Jenna M.
    Turina, Claire B.
    Beer, Tomasz M.
    Hung, Arthur Y.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (05): : 190 - 195
  • [3] Dose-Escalated Radiation Therapy for Intermediate-Risk Prostate Cancer
    Liauw, Stanley L.
    Fricano, Janine
    Correa, David
    Weichselbaum, Ralph R.
    Jani, Ashesh B.
    CANCER, 2009, 115 (08) : 1784 - 1790
  • [4] Impact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer
    Pons-Llanas, O.
    Collado-Ballesteros, E.
    Roldan-Ortega, S.
    Conde-Moreno, A.
    Celada-Alvarez, F.
    Martinez-Arcelus, F.
    Perez-Calatayud, M. J.
    Carmona-Meseguer, V
    Gimeno-Olmos, J.
    Forner-Ferrer, V
    Tormo-Mico, A.
    Perez-Calatayud, J.
    Lopez-Torrecilla, J.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (04) : 463 - 469
  • [5] Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?
    Soyano, Takashi
    Kozuka, Takuyo
    Kashihara, Kenichi
    Murakami, Yu
    Yonese, Junji
    Sasamura, Kazuma
    Shimoyachi, Nana
    Kashihara, Tairo
    Yoshioka, Yasuo
    Oguchi, Masahiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (06) : 514 - 521
  • [6] Dose-Escalated Stereotactic Body Radiation Improves Outcomes in Patients with Low- and Intermediate-Risk Prostate Cancer
    Cox, B. W.
    Rana, Z.
    Lee, L.
    Potters, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E105 - E105
  • [7] Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients
    Marina, Ovidiu
    Gustafson, Gary S.
    Kestin, Larry L.
    Brabbins, Donald S.
    Chen, Peter Y.
    Ye, Hong
    Martinez, Alvaro A.
    Ghilezan, Michel I.
    Wallace, Michelle
    Krauss, Daniel J.
    BRACHYTHERAPY, 2014, 13 (01) : 59 - 67
  • [8] Variations in Patterns of Concurrent Androgen Deprivation Therapy (ADT) Use Based on Standard Dose Versus Dose-Escalated Radiation Therapy (DE RT) for Prostate Cancer
    Mohiuddin, J. J.
    Narayan, V.
    Venigalla, S.
    Vapiwala, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E130 - E130
  • [9] Androgen Deprivation Therapy and Dose-Escalated Radiotherapy for Intermediate-and High-Risk Prostate Cancer Reply
    Falchook, Aaron D.
    Basak, Ramsankar
    Chen, Ronald C.
    JAMA ONCOLOGY, 2017, 3 (02) : 281 - 281
  • [10] Dose-Escalated Radiotherapy for Prostate Cancer Is the Sky the Limit?
    Gray, Phillip J.
    Zietman, Anthony L.
    JAMA ONCOLOGY, 2015, 1 (07) : 883 - 884
12345